Nobel Winner Attacks Sandoz Biosimilar Subpoena
A Nobel Prize-winning researcher has moved to block a Sandoz Inc. subpoena seeking testimony related to a biosimilar of Amgen Inc.'s blockbuster immunosuppressant Enbrel, telling a Texas federal court that the...To view the full article, register now.
Already a subscriber? Click here to view full article